Health minister Aaron Motsoaledi is livid about a pharmaceutical company campaign he says will restrict access to crucial drugs.

A generic version of a key cancer drug is now available in South Africa, but at a significantly higher cost than it is available internationally.

Patients in the world’s poorest countries will continue to receive access to drugs cheaply for at least another decade.

Pharmaceutical manufacturers in the country say their backs are up against the wall due to unfair import rules that give South Africa an advantage.

After a seven-year battle, India’s government has successfully defended its right to reject drug patents if a medicine doesn’t deserve one.

A global squabble over property rights could see the price of medicine soar in poor countries.

A new book detailing how profit-hungry pharmaceutical companies mislead medical practitioners and harm patients may be just what the doctor ordered.

It’s been a long journey of discovery for the family of a Cape Town girl who suffers from cystinosis.

Pfizer is buying rival drug maker Wyeth in a -billion deal that will increase its revenue by 50 percent and solidify its No 1 rank in the industry.

Pfizer Inc was close to a -billion purchase of US rival Wyeth in a move to diversify its revenue base, sources familiar with the situation said.